Cha Biotech to Acquire Additional Cha Healthcare Shares for 153.9 Billion Won
Cha Biotech announced on June 26 that it will acquire an additional 5,919,732 shares of Cha Healthcare, its overseas healthcare network operation and investment development subsidiary, for approximately 153.9 billion won. After the acquisition, Cha Biotech's stake in Cha Healthcare will increase to 81.7%.
Hot Picks Today
"I Ate at Home to Save Money, But My Account Balance Was Still a Shock"
- Suddenly Called Out During Class, Awarded $100,000 as Students Cheer in the Gym
- "Bought It Cheaper in Japan Than Korea"... Improper Use Leads to Vomiting and Abdominal Pain, Official Warning Issued
- "After a Dream About Feces, Bought a Lottery Ticket and Won 20,000 Won... Scratched Again and Hit a 2 Billion Won Jackpot"
- "Uncle Will Buy Them All for Wonie"... Men in Their 30s Sweep Up 600,000 'RESCENE Bread'
Cha Biotech explained that this share acquisition is "a precedent condition under the share purchase agreement to transfer part of the shares held in our subsidiary, Cha Healthcare Co., Ltd., to the PiumAI Future Healthcare Fund."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
